Related Experiment Videos
Renal cell carcinoma and interleukin-2: what are the endpoints?
The Cancer Journal From Scientific American
|February 11, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma.
European journal of cancer (Oxford, England : 1990)·2014
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma.
British journal of cancer·2014
Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
The cancer journal from Scientific American·2000
Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
The cancer journal from Scientific American·2000
Negative margin status improves local control in conservatively managed breast cancer patients.
The cancer journal from Scientific American·2000
The value of postlumpectomy mammogram in the management of breast cancer patients presenting with suspiciouis microcalcifications.
The cancer journal from Scientific American·2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
The cancer journal from Scientific American·2000
Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
The cancer journal from Scientific American·2000
Assessment of Natural Killer Cell Serial Degranulation.
Current protocols·2026
Stimuli-responsive nanocarriers for precision cation channel therapy.
Chemical communications (Cambridge, England)·2026
Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer's disease neuropathology: Preliminary observations.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026